Patenting Nanomedicines

Legal Aspects, Intellectual Property and Grant Opportunities

  • Eliana B. Souto

Table of contents

  1. Front Matter
    Pages i-xxiii
  2. Fundamentals

    1. Front Matter
      Pages 1-1
    2. Shivanand P. Puthli, Meenal S. Puthli, Ana Sofia Macedo, Eliana B. Souto
      Pages 3-24
    3. Rayasa S. Ramachandra Murthy
      Pages 25-48
    4. Viness Pillay, Yahya E. Choonara, Pradeep Kumar, Valence M. K. Ndesendo, Lisa C. du Toit
      Pages 49-96
  3. Case Studies in Patenting Drug Delivery and Targeting Systems

    1. Front Matter
      Pages 97-97
    2. Javed Ali, Shadab Md, Sanjula Baboota, Jasjeet K. Sahni
      Pages 99-149
    3. Tatiana Andreani, Ana Luiza R. de Souza, Amélia M. Silva, Eliana B. Souto
      Pages 151-166
    4. Gerardo Caruso, Mariella Caffo, Giuseppe Raudino, Chiara Tomasello, Concetta Alafaci, Francesco Tomasello
      Pages 167-203
    5. Anisha D’Souza, Sandhya Pranatharthiharan, Padma V. Devarajan
      Pages 205-249
    6. Vikas Bali, Sumita Singh, Ajay Kumar
      Pages 251-275
    7. Ali A. Al-Kinani, Gianpiero Calabrese, Anil Vangala, Declan Naughton, Raid G. Alany
      Pages 277-303
    8. Mine Özyazıcı, Evren Homan Gökçe, Aysu Yurdasiper
      Pages 305-343
    9. Tin Wui Wong, Uttamkumar Mandal, Li-Jiuan Shen
      Pages 345-374
    10. Rosita Saraceno, Andrea Chiricozzi, Elisabetta Botti, Talia Gramiccia, Lucia Pietroleonardo, Sergio Chimenti
      Pages 383-399
    11. Kamalinder K. Singh
      Pages 401-434
    12. Joana F. Fangueiro, Patrícia Severino, Selma B. Souto, Eliana B. Souto
      Pages 435-450
  4. Back Matter
    Pages 451-457

About this book


The book focusses on the fundamental aspects of Patenting Nanomedicines applied in different “Drug Delivery and Targeting Systems”. The promoters of new findings in this field of research are numerous and spread worldwide; therefore, managing intellectual property portfolios, and the acquisition and exploitation of new knowledge face several contingency factors. Major concerns include questions as to whether the research groups, academics, industry and other stakeholders should work in unison or independently, if innovation or adaptation of new technology should be prioritized, public versus private research funding, and safeguarding versus sharing knowledge. However, despite its increasing importance for humankind, it is a matter of concern as to whether technological development can really be stimulated by patent protection. An intellectual property strategy should aim to develop a qualitative patent portfolio for continuous learning.

This book addresses questions of ethics, socio-political policies and regulatory aspects of novel Nanomedicine-based products which are currently under development for the diagnosis and treatment of different types of diseases. It is divided in two parts – Part I is composed of the first 3 chapters, which focus on the “fundamentals” of legal aspects, emerging threats, advantages and disadvantages of patenting Nanomedicines, whereas Part II collects 12 chapters discussing different types of Nanomedicine-based products, their potential marketing aspects and patent protection. Whenever applied, each chapter offers a list of patents, based on a specific application in drug delivery and targeting. An outstanding team of 53 authors have contributed to this book, which will be of interest to professionals from the field of patent examiners, academics, researchers and scientists, students and other practitioners.


Ethics Nanomedicines Nanoparticles Nanotechnology Patents

Editors and affiliations

  • Eliana B. Souto
    • 1
  1. 1., Faculty of Health SciencesUniversity Fernando PessoaPortoPortugal

Bibliographic information